Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Emsley, R. Articles by Medori, R. Search for Related Content PubMed Citation Articles by Emsley, R. Articles by Medori, R. Atypical Neuroleptics Conventional Neuroleptics Schizophrenia Spectrum Disorders

Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia

OBJECTIVE: The authors examined early onset of antipsychotic action and early prediction of nonresponse to antipsychotics in patients with first-episode schizophrenia. METHOD: Time to clinical response (20% improvement in total score on the Positive and Negative Syndrome Scale [PANSS]) was determined in 522 participants in a randomized, controlled trial comparing risperidone and haloperidol. Median treatment length was 206 days. RESULTS: Clinical response was achieved in 77% (N=400) of subjects. Among these patients, clinical response was achieved in 23.3%, 23.3%, 18.5%, and 12.5% at weeks 1, 2, 3, and 4, respectively, after treatment initiation. However, in 22.5% of patients, response was not achieved until after 4 weeks, and in 11.2%, it was not achieved until after 8 weeks. In 45% of patients, response was achieved with a dose of 1–2 mg/day, in 27% with 3 mg/day, in 17% with 4 mg/day, and in the remaining 11% with higher doses. Improvement in the PANSS total score of at least 30%, 40%, and 50%, respectively, were achieved by 63.0%, 44.8%, and 27.5% of patients. CONCLUSIONS: Time to antipsychotic response varied widely, suggesting that, in first-episode schizophrenia, longer treatment trials may be necessary.

This article has been cited by other articles:

				S. H. Fatemi and T. D. Folsom The Neurodevelopmental Hypothesis of Schizophrenia, Revisited Schizophr Bull, May 1, 2009; 35(3): 528 - 548. [Abstract] [Full Text] [PDF]

				A. W. MacDonald and S. C. Schulz What We Know: Findings That Every Theory of Schizophrenia Should Explain Schizophr Bull, May 1, 2009; 35(3): 493 - 508. [Abstract] [Full Text] [PDF]

				L. Sikich, J. A. Frazier, J. McClellan, R. L. Findling, B. Vitiello, L. Ritz, D. Ambler, M. Puglia, A. E. Maloney, E. Michael, et al. Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study Am J Psychiatry, November 1, 2008; 165(11): 1420 - 1431. [Abstract] [Full Text] [PDF]

				S. Z. Levine and J. Rabinowitz Trajectories and Antecedents of Treatment Response Over Time in Early-Episode Psychosis Schizophr Bull, October 9, 2008; (2008) sbn120v1. [Abstract] [Full Text] [PDF]

				Other articles noted Evid. Based Ment. Health, November 1, 2006; 9(4): 92 - 92. [Full Text] [PDF]

				Other articles noted Evid. Based Ment. Health, August 1, 2006; 9(3): 64 - 64. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us